TrademarkOpen
Search / US trademark / 98899757
US trademark

STACKLOC

Registered

Status timeline

  1. 12 Dec 2024
    Application filed
    New Application Entered
  2. 18 Feb 2025
    Assigned to an examining attorney
    Assigned To Examiner
  3. 25 Feb 2025
    Office action issued
    Non-Final Action Written
  4. 6 Mar 2025
    Response to office action filed
    Teas Response To Office Action Received
  5. 10 Mar 2025
    Approved for publication
    Approved For Pub - Principal Register
  6. 1 Apr 2025
    Published for opposition
    Published For Opposition
  7. 27 May 2025
    Notice of allowance issued — statement of use required
    Noa E-Mailed - Sou Required From Applicant
  8. 20 Aug 2025
    Statement of use filed
    Teas Statement Of Use Received
  9. 23 Mar 2026
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  10. 14 Apr 2026
    Registered on the Principal Register
    Registered-Principal Register
All 22 USPTO events
2026-04-14Registered-Principal Register
2026-04-14Notice Of Registration Confirmation Emailed
2026-03-23Allowed Principal Register - Sou Accepted
2026-03-23Notice Of Acceptance Of Statement Of Use E-Mailed
2026-02-26Statement Of Use Processing Complete
2026-02-25Case Assigned To Intent To Use Paralegal
2025-08-20Teas Statement Of Use Received
2025-08-20Use Amendment Filed
2025-05-27Noa E-Mailed - Sou Required From Applicant
2025-04-01Published For Opposition
2025-04-01Official Gazette Publication Confirmation E-Mailed
2025-03-26Notification Of Notice Of Publication E-Mailed
2025-03-10Approved For Pub - Principal Register
2025-03-06Teas Response To Office Action Received
2025-03-06Correspondence Received In Law Office
2025-03-06Teas/Email Correspondence Entered
2025-02-25Non-Final Action Written
2025-02-25Non-Final Action E-Mailed
2025-02-25Notification Of Non-Final Action E-Mailed
2025-02-18Assigned To Examiner
2024-12-12New Application Entered
2024-12-12New Application Office Supplied Data Entered

Goods & services

Class 5 Pharmaceuticals & supplements

Pharmaceutical feature in the nature of proprietary nutrient-delivery agents that enhance nutrient absorption and bioavailability, namely, a feature in the nature of nutrient delivery agents in the form of powders that provide controlled release of active ingredients for a wide variety of dietary supplements, nutritional supplements, and pharmaceutical preparations, sold as an integral component of dietary supplements, nutritional supplements, and pharmaceutical preparations for the treatment of cardiovascular, neurological, cognitive, digestive, inflammatory, anxiety, weight management, and metabolic health conditions.

First use anywhere 7 Apr 2025 · First use in commerce 7 Apr 2025

Source & freshness

Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 15 Apr 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.